SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
ARS

An annual report to security holders

Annual Filings
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML

Data provided by Kaleidoscope.